West Pharmaceutical Services (WST) Set to Announce Quarterly Earnings on Thursday

West Pharmaceutical Services (NYSE:WST) is set to issue its quarterly earnings data before the market opens on Thursday, October 24th. Analysts expect the company to announce earnings of $1.51 per share for the quarter. West Pharmaceutical Services has set its FY 2024 guidance at 6.350-6.650 EPS.Individual interested in participating in the company’s earnings conference call can do so using this link.

West Pharmaceutical Services (NYSE:WST) last posted its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The business had revenue of $702.10 million during the quarter, compared to the consensus estimate of $729.36 million. During the same period in the previous year, the business earned $2.11 earnings per share. The firm’s revenue for the quarter was down 6.9% compared to the same quarter last year. On average, analysts expect West Pharmaceutical Services to post $6 EPS for the current fiscal year and $8 EPS for the next fiscal year.

West Pharmaceutical Services Trading Down 0.7 %

NYSE:WST opened at $288.95 on Thursday. West Pharmaceutical Services has a 12 month low of $265.00 and a 12 month high of $413.70. The company has a 50-day moving average price of $299.94 and a 200-day moving average price of $326.36. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The stock has a market cap of $20.96 billion, a price-to-earnings ratio of 41.10, a P/E/G ratio of 10.53 and a beta of 1.01.

Insider Buying and Selling at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total value of $308,700.00. Following the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.53% of the stock is owned by company insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.